Recovery of patients with gout
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
349 10
Ultima descărcare din IBN:
2023-09-07 08:52
Căutarea după subiecte
similare conform CZU
616.72-002.78-036.82 (1)
Patologia organelor de locomoţie. Sistemul osos şi locomotor (469)
SM ISO690:2012
ROTARU, Larisa, GROPPA, Liliana, POPA, Serghei, NURSEITOVA, Tamilla, CORNEA, Cornelia. Recovery of patients with gout. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3(29), pp. 54-57. ISSN 2345-1467. DOI: https://doi.org/10.52645/MJHS.2022.3.10
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Revista de Ştiinţe ale Sănătăţii din Moldova
Numărul 3(29) / 2022 / ISSN 2345-1467

Recovery of patients with gout

DOI:https://doi.org/10.52645/MJHS.2022.3.10
CZU: 616.72-002.78-036.82

Pag. 54-57

Rotaru Larisa12, Groppa Liliana21, Popa Serghei1, Nurseitova Tamilla3, Cornea Cornelia1
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Timofei Moșneaga Republican Clinical Hospital,
3 "Dunarea de Jos" University of Galati
 
 
Disponibil în IBN: 6 noiembrie 2022


Rezumat

Introduction. The incidence and prevalence of gout have increased worldwide in recent decades. Scientists at the Rochester Epidemiology Project (MN, USA) have seen a two-fold increase in the incidence of primary gout (patients without diuretic exposure) over a 20-year period, which ended in 1996. The increase of incidence may be related due to the difficulty and often unsatisfactory treatment options. The aim of the study was to systematize the recommendations on dietary treatment, and medication for patients with gout. Materials and methods. An analytical, qualitative, and secondary study was performed in the form of a synthesis article. 115 sources were identified and analyzed; from this list, 44 sources were selected according to the impact score during the publication period and according to the level of recommendations.Results. 44 articles were included. Most studies were small, retrospective analyses performed in single centers, with concerns for bias. Eleven studies (including five randomized controlled trials) reported improved patient outcomes following pharmacological interventions with known efficacy in gout, including allopurinol, prednisolone, NSAIDs and anakinra. Eight studies reported improved outcomes associated with non-pharmacological interventions: inpatient rheumatology consultation and a hospital gout management protocol. No studies to date have prospectively evaluated strategies designed to prevent re-admissions of patients hospitalized for gout flares. Conclusions. Urate crystals is completely soluble when we can lower the serum level of uric acid to normal values, but this often requires long-term treatment. The early onset of rehabilitation of affected joints helps to reduce the articular inflammatory process, the pain syndrome and it delays the progression of the underlying pathology while improving the quality of life in patients with gout. Further research is needed to enable healthcare providers to individualize and optimize gout treatment strategies, ensuring that patients with gout receive effective, safe, and high-quality care.

Cuvinte-cheie
gout, recovery, management, prevention